glp-1 for weight loss without diabetes is driven mainly by fat loss, not muscle loss Losing the Weight Loss Meds:

Jahrestagung der American Academy of Ophthalmology wurden zwei neue Studien zur Einnahme von GLP-1-Medikamenten im Zusammenhang mit Augenerkrankungen vorgestellt mit gemischten Ergebnissen

See the FDA update and the MoCRA overview

While it remains to be established if specifically inhibiting LC-NE neurons has a similar effect, these findings suggest that systemic GLP-1R agonists activate presynaptic GLP-1Rs on glutamatergic terminals synapsing onto LC-NE neurons, leading to their activation and suppression of food intake

Nausea represents the most frequently reported adverse reaction, affecting a significant proportion of patients, particularly during the initial weeks of therapy or following dose increases

It swiftly brightens skin by converting melanin, deactivating tyrosinase, the enzyme that produces pigment, and promoting a lighter colour